Shine-On BioMedical ,Ltd. Profit Margin

As of the most recent data (June 2026), 6926.TWO shows a profit margin of -590.29%. That compares with -1029.28% in the prior-year period — up 42.7% year over year. That is below the Healthcare sector average of 10.58%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6926.TWO's profit margin is now -590.29% (was -1029.28%) — a 42.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Shine-On BioMedical ,Ltd. is outperforming or lagging.

The Healthcare sector average profit margin is about 10.58%. Shine-On BioMedical ,Ltd. is at -590.29%, which is lower that average. That is roughly 5679.1% below the sector mean. Use the comparison chart on this page to see how 6926.TWO stacks up against individual peers as well.

That compares with -1029.28% in the prior-year period — up 42.7% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Shine-On BioMedical ,Ltd. with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Shine-On BioMedical ,Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -590.29%) with ownership activity and broader fundamentals.